Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
2021
2020
2019
Profitability Metrics
Gross Margin
33.38%
Operating Margin
13.24%
Net Margin
11.95%
Efficiency Metrics
Revenue per Expense Ratio
1.15
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
18.00%
Income Tax Rate
23.36%
EPS
1.2800000000
Balance Sheet Analysis
Current Ratio
3.59
Cash Ratio
1.81
Working Capital
$245.76M
Debt to Equity
0.02
Debt to Assets
1.47%
Equity Ratio
75.93%
Cash Flow Analysis
Operating Cash Flow Ratio
12.30%
Free Cash Flow Ratio
8.81%
CapEx to Revenue
3.48%
Dividends Paid
$25.08M
Stock Buybacks
$33.11M
Total Shareholder Returns
$58.19M
Cash Position Change
42.24%
Key Takeaways (2023 FY)
Maintained positive net income growth despite revenue changes
Increased dividend payments by 3.37%
Detailed Growth Metrics
Core Performance
Revenue
12.90%
Net Income
21.04%
EPS
23.08%
Operating Income
-8.06%
Operational Efficiency
R&D Expenses
0.00%
SG&A Expenses
27.08%
Operating Cash Flow
31.31%
Free Cash Flow
39.26%
Balance Sheet Health
Assets
6.44%
Debt
19.57%
Book Value per Share
6.74%
Inventory
12.64%
Shareholder Returns
Dividends per Share
3.37%
Shares Outstanding
-1.50%
Long Term Trends
3Y Revenue/Share
70.00%
5Y Revenue/Share
53.34%
3Y Dividend/Share
9.62%
5Y Dividend/Share
12.87%